Healthy Skepticism Library item: 6835

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

Publication type: news

O’hara J.
Whistle-blower: a top researcher says a drug under trial poses a risk to patients
Maclean’s 1998 Nov 16

Abstract:

A detailed account about the battle between Dr. Nancy Olivieri, Apotex, the Hospital for Sick Children and the University of Toronto around the drug deferiprone. Olivieri was doing research on this product for Apotex, when she became concerned that the drug was causing liver damage. When she tried to take her concerns to Apotex she was threatened with legal action. Both the Hospital for Sick Children and the University of Toronto refused to support her.

Keywords:
*feature story/Canada/Apotex/Hospital for Sick Children/University of Toronto/ deferiprone/ drug company sponsored research/ disinformation/ intimidation/ reaction to critics/ relationship between researchers, academic institutions and industry/ETHICAL ISSUES IN PROMOTION: ETHICS OF TRIALS/ETHICAL ISSUES IN PROMOTION: LINKS BETWEEN HEALTH PROFESSIONALS AND INDUSTRY/SPONSORSHIP: RESEARCH